According to Acorda Therapeutics
's latest financial reports the company's current revenue (TTM ) is S$0.15 Billion. In 2023 the company made a revenue of S$0.15 Billion a decrease over the revenue in the year 2022 that were of S$0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | S$0.15 B | 0.18% |
2023 | S$0.15 B | -2.26% |
2022 | S$0.15 B | -8.91% |
2021 | S$0.17 B | -13.77% |
2020 | S$0.20 B | -21.99% |
2019 | S$0.25 B | -59.72% |
2018 | S$0.64 B | -18.15% |
2017 | S$0.78 B | 4.63% |
2016 | S$0.75 B | 7.91% |
2015 | S$0.69 B | 31.37% |
2014 | S$0.53 B | 24.46% |
2013 | S$0.42 B | 13.98% |
2012 | S$0.37 B | -1.18% |
2011 | S$0.37 B | 53.82% |
2010 | S$0.24 B | 220.54% |
2009 | S$76.75 M | 12.22% |
2008 | S$68.39 M | 20.37% |
2007 | S$56.82 M | 35.48% |
2006 | S$41.93 M |